LENSAR, Inc.
LENSAR, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 14 | 12 | 13 | 8 | 7 | 20 | 16 | 10 | 8 | 14 | 21 | 25 | |||||
Short Term Investments | 0 | 1 | 5 | 9 | 13 | 6 | 6 | 8 | 6 | 4 | 3 | - | |||||
Accounts Receivable Net Current | 6 | 5 | 6 | 6 | 5 | 7 | 6 | 4 | 6 | 4 | 4 | 4 | |||||
Notes And Loans Receivable Net Current | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Inventory Net | 25 | 23 | 22 | 21 | 19 | 15 | 11 | 15 | 18 | 18 | 16 | 17 | |||||
Prepaid Expense And Other Assets Current | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Assets Current | 47 | 42 | 47 | 44 | 46 | 49 | 42 | 39 | 40 | 42 | 46 | 49 | |||||
Property Plant And Equipment Net | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | |||||
Long Term Investments | - | - | - | - | - | - | - | 0 | 1 | 1 | 0 | - | |||||
Notes And Loans Receivable Net Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Finite Lived Intangible Assets Net | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 7 | 11 | 11 | 11 | |||||
Other Assets Noncurrent | 2 | 3 | 3 | 3 | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | |||||
Assets | 70 | 66 | 71 | 70 | 70 | 73 | 66 | 62 | 61 | 66 | 70 | 71 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 11 | 10 | 19 | 15 | 11 | 8 | 6 | 4 | 4 | 4 | 4 | 4 | |||||
Accrued Liabilities Current | 5 | 4 | 8 | 8 | 6 | 7 | 7 | 6 | 4 | 4 | 6 | 5 | |||||
Contract With Customer Liability Current | 3 | 3 | 3 | 2 | 3 | 2 | 2 | 1 | 1 | 2 | 1 | 1 | |||||
Operating Lease Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Liabilities Current | 20 | 18 | 41 | 36 | 30 | 27 | 15 | 12 | 10 | 10 | 12 | 11 | |||||
Long Term Notes Payable | 4 | 5 | - | - | - | - | - | - | - | - | - | - | |||||
Operating Lease Liability Noncurrent | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | |||||
Other Liabilities Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | |||||
Liabilities | 41 | 42 | 84 | 82 | 80 | 81 | 48 | 25 | 24 | 21 | 22 | 21 | |||||
Temporary Equity Carrying Amount Including Portion… | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 152 | 152 | 151 | 150 | 149 | 148 | 148 | 147 | 147 | 146 | 145 | 144 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | -0 | -0 | 0 | - | |||||
Retained Earnings Accumulated Deficit | -138 | -141 | -178 | -176 | -172 | -171 | -143 | -125 | -123 | -114 | -112 | -108 | |||||
Stockholders Equity | 15 | 11 | -26 | -26 | -23 | -22 | 5 | 23 | 24 | 32 | 33 | 36 | |||||
Liabilities And Stockholders Equity | 70 | 66 | 71 | 70 | 70 | 73 | 66 | 62 | 61 | 66 | 70 | 71 | |||||
Allowance For Doubtful Accounts Receivable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Allowance For Notes And Loans Receivable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Allowance For Notes And Loans Receivable Noncurren… | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Temporary Equity Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Temporary Equity Shares Authorized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Temporary Equity Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Temporary Equity Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Temporary Equity Liquidation Preference | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | |||||
Common Stock Shares Issued | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 11 | 11 | 11 | |||||
Shares Outstanding | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 11 | 11 | 11 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 2.84% | -0.18% | -0.71% | - | - | - | - | - | - | - | - | - |
| 2025 | -2.03% | -7.60% | -5.50% | -4.36% | -3.82% | -6.78% | -11.01% | 4.46% | 9.35% | -14.60% | 2.18% | -3.69% |
| 2024 | 23.04% | 17.80% | 42.41% | 17.04% | 11.28% | 32.83% | 9.61% | 21.98% | 37.12% | 36.34% | 27.97% | 29.81% |
| 2023 | - | - | - | - | - | - | 13.27% | 55.31% | 69.91% | -29.67% | -32.92% | -13.25% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 2.39 | 2.38 | 1.15 | 1.24 | 1.52 | 1.81 | 2.80 | 3.37 | 3.88 | 4.06 | 3.99 | 4.42 | |||||
| Quick Ratio | 1.03 | 1.05 | 0.61 | 0.65 | 0.85 | 1.20 | 1.93 | 1.95 | 1.97 | 2.13 | 2.44 | 2.64 | |||||
| Working Capital | 27.39M | 24.60M | 6.20M | 8.70M | 15.78M | 22.01M | 26.98M | 27.72M | 29.86M | 31.99M | 34.81M | 37.63M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 2.74 | 3.86 | -3.22 | -3.18 | -3.46 | -3.67 | 9.80 | 1.12 | 1.01 | 0.65 | 0.67 | 0.57 | |||||
| Debt Ratio | 0.59 | 0.63 | 1.17 | 1.17 | 1.13 | 1.11 | 0.72 | 0.41 | 0.39 | 0.31 | 0.32 | 0.29 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.84 | 0.83 | 0.85 | 0.78 | 0.77 | 0.71 | 0.68 | 0.68 | 0.65 | 0.72 | 0.67 | 0.57 | |||||
| Days Sales Outstanding TTM | 34.69 | 37.13 | 38.92 | 36.17 | 39.01 | 40.14 | 40.05 | 33.20 | 38.53 | 37.24 | 43.46 | 37.77 | |||||
| Receivables Turnover TTM | 10.52 | 9.83 | 9.38 | 10.09 | 9.36 | 9.09 | 9.11 | 11.00 | 9.47 | 9.80 | 8.40 | 9.66 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 1.51 | 1.91 | -2.87 | -4.28 | -4.13 | -4.81 | -2.73 | -1.43 | -1.10 | -1.08 | -1.31 | -1.08 | |||||
| Free Cash Flow Per Share TTM | -0.81 | -1.01 | -1.25 | -0.41 | 0.14 | -0.34 | -0.21 | -0.57 | -0.88 | -0.75 | -0.90 | -1.28 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 46.96% | 45.90% | 46.41% | 38.56% | 39.40% | 40.01% | 39.86% | 44.74% | 47.61% | 48.18% | 50.06% | 50.12% | |||||
| Operating Profit Margin TTM | -13.84% | -28.58% | -42.06% | -40.41% | -28.71% | -27.43% | -23.20% | -27.29% | -30.41% | -25.19% | -29.00% | -33.20% | |||||
| Net Profit Margin TTM | 59.11% | 50.77% | -58.66% | -99.40% | -96.89% | -114.11% | -68.33% | -36.79% | -29.08% | -28.83% | -34.11% | -36.17% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 15.33% | 16.76% | 27.14% | 14.69% | 17.88% | 16.55% | 9.01% | 26.28% | 27.95% | 50.07% | 43.21% | -0.78% | |||||
| Net Income Growth (1Y) | -170.36% | -151.95% | 9.16% | 209.86% | 292.68% | 361.30% | 118.34% | 28.43% | -35.62% | -29.95% | -27.77% | -39.29% | |||||
| EPS Growth (1Y) | -168.30% | -150.29% | 5.14% | 198.54% | 276.69% | 346.14% | 107.97% | 22.88% | -39.17% | -34.07% | -33.12% | -44.09% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 2.02 | 2.47 | -4.06 | -2.89 | -3.19 | -2.94 | -3.28 | -3.20 | -4.10 | -3.15 | -2.68 | -2.65 | |||||
| P/B TTM | 4.71 | 6.72 | -5.34 | -5.74 | -6.82 | -7.51 | 21.18 | 2.34 | 2.18 | 1.22 | 1.15 | 0.94 | |||||
| P/S TTM | 1.20 | 1.25 | 2.38 | 2.87 | 3.09 | 3.35 | 2.24 | 1.18 | 1.19 | 0.91 | 0.91 | 0.96 | |||||
| Market Cap | 70.22M | 72.48M | 139.07M | 148.74M | 157.21M | 166.25M | 102.97M | 53.15M | 51.53M | 38.68M | 38.51M | 34.31M | |||||
| Enterprise Value | 60.40M | 64.99M | 126.10M | 141.11M | 150.06M | 146.70M | 86.71M | 42.70M | 43.24M | 24.72M | 17.89M | 9.39M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -9.96M | -12.24M | -14.91M | -4.94M | 1.71M | -4.05M | -2.43M | -6.61M | -10.08M | -8.52M | -9.90M | -14.19M | |||||
| Net Debt | -9.82M | -7.49M | -12.97M | -7.64M | -7.15M | -19.55M | -16.26M | -10.44M | -8.29M | -13.96M | -20.62M | -24.92M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
LENSAR, Inc. (LNSR) — SEC Financial Statements & Analysis
LENSAR, Inc. (LNSR) is a surgical & medical instruments & apparatus company, incorporated in DE. LENSAR, Inc. trades on Nasdaq as: LNSR. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), LENSAR, Inc. reported a 15.33% year-over-year revenue growth, a Gross Profit Margin of 46.96% (TTM), a Debt-to-Equity ratio of 2.74x, a Price-to-Sales (P/S) ratio of 1.20x (TTM), a Price-to-Book (P/B) ratio of 4.71x (TTM), at a market cap of $70.22M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 15.33%
- Gross Profit Margin TTM
- 46.96%
- Debt To Equity
- 2.74x
- P/S TTM
- 1.20x
- P/B TTM
- 4.71x
- Market Cap
- $70.22M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is LENSAR, Inc. in?
LENSAR, Inc. (LNSR) operates in the Surgical & Medical Instruments & Apparatus industry.
What is LNSR's market cap?
LENSAR, Inc. (LNSR) has a market capitalization of $70.22M as of 2026-06-30.
What is LNSR's P/E ratio?
LENSAR, Inc. (LNSR)'s trailing twelve month P/E ratio is 2.02x as of 2026-06-30.
What exchange does LNSR trade on?
LENSAR, Inc. (LNSR) trades on the Nasdaq.
Where is LENSAR, Inc. incorporated?
LENSAR, Inc. is incorporated in DE.